Recombinant VEGF (Bevacizumab Biosimilar) anticorps

N° du produit ABIN7093077

Détail du produit anti-VEGF (Bevacizumab Biosimilar) anticorps

Antigène: VEGF (Bevacizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Humanized

Clonalité: Monoclonal

Conjugué: Cet anticorp VEGF (Bevacizumab Biosimilar) est non-conjugé

Application: ELISA

Fonction: Anti-VEGFA (bevacizumab biosimiar) mAb

Attributs du produit: Also known as: MVCD1,VEGF,VPF

Purification: Purified from cell culture supernatant by affinity chromatography

Classe de qualité: Research Grade

Isotype: IgG1

Information d'application

Indications d'application: ELISA 1:5000-10000

Commentaires:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4, 0.1 % Procline 300. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized proteins are shipped at ambient temperature.

Date de péremption: 12 months

Détails sur VEGF (Bevacizumab Biosimilar)

Antigène: VEGF (Bevacizumab Biosimilar)

Autre désignation: VEGFA (Bevacizumab Biosimiar) (VEGF (Bevacizumab Biosimilar) Produits)

Synonymes: anticorps MVCD1, anticorps VEGF, anticorps VPF, anticorps vascular endothelial growth factor A, anticorps VEGFA

Classe de substances: Biosimilar

Sujet: Synonyms: rhuMAb-VEGF

ID gène: 7422

UniProt: P15692